节点文献

外周化疗性静脉炎的发病机制及防治进展

Research progress on the pathogenesis and prevention of peripheral chemotherapy-induced phlebitis

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 容桂荣文琼仙

【Author】 RONG Guirong;WEN Qiongxian;The Affiliated Hospital of Guilin Medical University;

【通讯作者】 文琼仙;

【机构】 桂林医学院附属医院

【摘要】 外周静脉输注化疗药物可致静脉炎的发生,发生率可高达70%以上,严重者可影响化疗进程。其发病机制主要与药物的pH值、浓度、输液速度等因素有关。水胶体、中成药、各类活血化瘀药等局部外敷有一定疗效。笔者将化疗性静脉炎的定义、发病机制、药物防治现状进行综述。

【Abstract】 Phlebitiscan be caused by peripheral intravenous injection of chemotherapy drugs, and theincidence can be as high as 70%. It can affect the course of chemotherapy if it is serious.The pathogenesis is mainly related to the Ph value, concentration and infusion speedof drugs.The local external application ofhydrocolloid, Chinese traditional medicine,and various kinds of other medicines for promoting blood circulation and removing blood stasis may have certain curative effect on phlebitis.This paper reviews the definition of chemotherapy-induced phlebitis,its pathogenesis,and the current situation of its prevention and treatment by drugs.

【关键词】 静脉炎化疗防治措施
【Key words】 phlebitischemotherapymeasures of prevention and treatment
【基金】 广西医疗卫生适宜技术开发与推广应用项目(S2019064);桂林医学院中青年教职工科研能力提升项目资助课题(2018glmcy086)
  • 【文献出处】 华夏医学 ,Acta Medicinae Sinica , 编辑部邮箱 ,2020年03期
  • 【分类号】R473.73
  • 【被引频次】5
  • 【下载频次】483
节点文献中: 

本文链接的文献网络图示:

本文的引文网络